acut
respiratori
distress
syndrom
ard
indic
acut
lung
injuri
ali
highli
associ
sepsi
pneumonia
sever
acut
respiratori
syndrom
sar
pathogenesi
ard
involv
releas
proinflammatori
mediat
tumor
necrosi
factor
tnf
nitric
oxid
among
other
high
level
product
earli
warn
signal
aggrav
lung
injuri
activ
alveolar
macrophag
neutrophil
also
caus
excess
product
via
express
induc
nitric
oxid
synthas
ino
high
mobil
group
late
act
cytokin
also
contribut
signific
lung
damag
although
may
express
earlier
differ
diseas
model
patient
ard
endotoxem
anim
earli
increas
late
elev
lung
epithelium
fluid
plasma
accordingli
proinflammatori
mediat
upstream
signal
pathway
may
play
critic
role
pathogenesi
ali
blockad
tnf
releas
may
lessen
sever
lpsinduc
ali
ard
character
diffus
alveolar
damag
format
hyalin
membran
proteinrich
edema
fluid
alveolar
space
capillari
injuri
disrupt
alveolar
epithelium
studi
demonstr
pretreat
variou
candid
drug
nonsteroid
antiinflammatori
drug
nsaid
corticosteroid
natur
product
prevent
delay
sever
inflammatori
respons
benefici
effect
pretreat
drug
howev
assur
effect
acut
manag
ie
posttreat
sepsi
syndrom
fact
posttreat
drug
significantli
reduc
lung
injuri
mortal
due
ard
remain
high
polyphenol
exhibit
antiinflammatori
effect
major
compon
mani
tradit
herbal
remedi
oroxylin
oroa
activ
compon
scutellaria
radix
huang
qin
biphenol
compound
inhibit
activ
transcript
factor
lead
reduct
lipopolysaccharid
lp
induc
ino
express
raw
cell
result
suggest
oroa
potenti
use
therapeut
agent
treat
acut
lung
injuri
induc
lp
therefor
investig
effect
posttreat
oroa
lpsinduc
lung
inflamm
fatal
rat
mice
respect
find
indic
first
time
posttreat
oroa
hr
lp
challeng
significantli
reduc
lung
inflamm
accompani
reduct
cytoplasm
plasma
pulmonari
edema
posttreat
also
significantli
increas
surviv
rate
lpschalleng
endotoxem
mice
chang
circulatori
paramet
includ
wbc
number
rat
model
lpsinduc
acut
lung
injuri
ali
earlier
hr
lp
middl
hr
lp
later
hr
lp
stage
examin
initi
signific
decreas
circul
wbc
peak
hr
lp
mgkg
iv
challeng
found
fig
wbc
count
slowli
return
basal
level
hr
lp
challeng
oroa
mgkg
iv
administ
hr
lp
challeng
prevent
decreas
facilit
recoveri
circul
wbc
hr
lp
administr
contrast
plasma
significantli
elev
peak
hr
follow
rapid
declin
basal
level
hr
lp
treatment
fig
administr
oroa
mgkg
iv
hr
post
lp
treatment
significantli
reduc
elev
hr
hr
lp
challeng
earlier
declin
basal
level
hr
lp
treatment
maintain
basal
level
hr
lp
challeng
fig
oroa
mgkg
iv
given
hr
lp
challeng
howev
significantli
alter
lp
effect
circul
wbc
plasma
data
shown
henc
posttreat
oroa
effect
revers
lpsinduc
wbc
reduct
suppress
enhanc
circul
level
lpsinduc
ali
fig
b
order
explor
therapeut
benefit
oroa
examin
oroa
posttreat
prevent
lpsinduc
patholog
chang
lung
tissu
differ
stage
inflamm
urethaneanesthet
rat
intraalveolar
septa
becam
significantli
thicker
fig
accumul
activ
alveolar
macrophag
inset
fig
hr
lp
treatment
mgkg
iv
administr
oroa
mgkg
iv
hr
lp
challeng
significantli
reduc
lpsinduc
accumul
activ
alveolar
macrophag
inset
attenu
thicken
intraalveolar
septa
fig
similar
result
found
oroa
mgkg
iv
administ
hr
lp
challeng
fig
oroa
mgkg
iv
alon
caus
notabl
sign
patholog
chang
fig
order
examin
whether
oroa
inhibit
enhanc
vascular
permeabl
prevent
lung
inflamm
induc
lp
pulmonari
edema
format
assay
perform
lp
mgkg
iv
treatment
significantli
increas
lung
wettodri
wd
weight
ratio
fig
examin
hr
lp
challeng
increas
reduc
significantli
oroa
mgkg
iv
administ
hr
hr
lp
treatment
fig
sever
lpsinduc
lung
injuri
evalu
lung
injuri
score
obtain
base
presenc
cell
infiltr
accumul
pulmonari
edema
andor
hemorrhag
lung
injuri
score
lpstreat
group
significantli
increas
increas
significantli
reduc
follow
oroa
treatment
mgkg
iv
hr
hr
follow
lp
challeng
fig
plasma
concentr
significantli
increas
lp
administr
mgkg
iv
anesthet
rat
fig
increas
significantli
reduc
oroa
mgkg
iv
administ
hr
fig
hr
fig
lp
challeng
furthermor
hr
lp
treatment
mgkg
iv
ino
significantli
express
small
conduct
bronchiol
clara
cell
inset
fig
also
numer
inosposit
macrophag
found
intraalveolar
septa
fig
express
significantli
inhibit
oroa
mgkg
iv
administ
hr
lp
challeng
fig
similarli
immunoblot
show
ino
product
examin
hr
lp
challeng
significantli
suppress
oroa
mgkg
iv
administ
hr
hr
lp
challeng
fig
later
phase
cytokin
releas
nuclei
cytoplasm
region
follow
lp
challeng
therefor
examin
oroa
inhibit
lpsinduc
releas
concentr
cytoplasm
rel
low
control
nonlpstreat
lung
tissu
significantli
elev
hr
lp
mgkg
iv
challeng
fig
elev
level
hr
significantli
reduc
oroa
mgkg
iv
administ
hr
hr
lp
challeng
fig
examin
whether
oroa
inhibit
lpsinduc
releas
mediat
inhibit
transcript
factor
activ
transloc
examin
hr
lp
mgkg
iv
challeng
cytoplasm
decreas
significantli
ie
enhanc
degrad
lung
tissu
compar
salsolv
treat
control
group
fig
decreas
significantli
revers
oroa
mgkg
iv
administ
hr
hr
lp
treatment
fig
parallel
activ
transloc
cytoplasm
nucleu
lpstreat
group
lead
decreas
cytosol
fig
increas
nucleu
fig
transloc
examin
hr
lp
treatment
inhibit
equal
oroa
mgkg
iv
given
hr
hr
lp
challeng
fig
furthermor
lp
treatment
caus
signific
phosphoryl
fig
phosphoryl
significantli
inhibit
oroa
mgkg
iv
given
hr
lp
treatment
fig
surviv
rate
key
indic
therapeut
benefit
oroa
examin
mice
accord
report
other
mice
given
lethal
dose
lp
mgkg
ip
induc
endotoxemia
less
lpstreat
mice
surviv
hr
fig
surviv
rate
differ
mous
strain
affect
mgkg
oroa
ip
administ
hr
lp
challeng
result
shown
significantli
improv
mgkg
oroa
ip
administ
hr
fig
hr
fig
lp
challeng
present
studi
demonstr
posttreat
oroa
significantli
attenu
lung
inflamm
improv
surviv
rate
lpsinduc
ali
rodent
benefici
effect
oroa
involv
suppress
signal
pathway
blockad
elev
circul
releas
nuclear
cytoplasm
accumul
macrophag
interstiti
space
thicken
intraalveolar
septa
lung
lpsinduc
lung
injuri
rat
frequent
use
model
studi
ali
present
find
larg
number
macrophag
pmn
lung
tissu
increas
endotheli
permeabl
tissu
damag
thicken
intraalveolar
septa
excess
product
inflammatori
cytokin
edema
lung
consist
report
other
furthermor
urethaneanesthet
rat
model
ali
use
present
studi
advantag
hemodynam
chang
monitor
continu
hr
possibl
howev
remain
benefici
effect
oroa
may
attribut
urethan
like
anesthet
ketamin
propofol
also
report
exhibit
protect
lpsinduc
endotoxemia
although
urethan
higher
concentr
gkg
ip
exhibit
antiinflammatori
effect
protect
rat
lethal
endotoxemia
reduc
releas
urethan
lower
concentr
gkg
ip
show
signific
protect
prevent
death
lp
challeng
present
result
also
indic
urethan
gkg
ip
alon
suppress
lpsinduc
product
ino
late
act
cytokin
sever
lung
inflamm
similar
result
found
consciou
rat
model
unanesthet
rat
unpublish
result
result
suggest
lpsinduc
patholog
chang
significantli
affect
urethan
concentr
use
present
studi
reason
protect
effect
oroa
urethaneanesthet
rat
like
due
urethan
gkg
ip
reason
urethan
gkg
ip
seem
work
addit
synergist
fashion
oroa
therebi
exagger
natur
abil
compound
result
strongli
support
protect
effect
oroa
urethan
gkg
ip
anesthet
rat
due
primarili
oroa
lp
stimul
migrat
circul
wbc
neutrophil
site
infect
promot
rapid
regul
immun
respons
present
result
indic
lp
challeng
circul
wbc
significantli
decreas
initi
follow
return
toward
normal
rang
later
stage
inflamm
result
consist
report
other
significantli
revers
oroa
administr
iv
similar
result
obtain
intraperiton
administr
oroa
unpublish
data
although
effect
oroa
lpsinduc
chang
wbc
per
se
remain
determin
data
indic
oroa
prepar
bioavail
iv
ip
administr
lp
also
activ
resid
alveolar
macrophag
neutrophil
caus
inflamm
ali
present
studi
found
interstiti
space
fill
activ
alveolar
macrophag
neutophil
follow
lp
challeng
patholog
chang
revers
oroa
posttreat
suggest
oroa
may
inhibit
lpsinduc
leukocyt
roll
transmigr
lung
tissu
addit
signific
lung
injuri
includ
edema
format
thicken
intraalveolar
septa
enhanc
lung
injuri
score
reduc
significantli
oroa
mgkg
iv
administ
hr
hr
lp
challeng
result
provid
evid
support
oroa
posttreat
effect
revers
lpsinduc
lung
injuri
examin
whether
oroa
effect
later
phase
lung
inflamm
inflammatori
cascad
activ
oroa
iv
mgkg
administ
hr
lp
treatment
also
significantli
lower
activ
macrophag
accumul
sequestr
suppress
pulmonari
edema
format
prevent
increas
septa
thick
find
suggest
oroa
effect
amelior
late
stage
lung
injuri
induc
lp
support
find
lpsinduc
express
semil
express
hr
lp
challeng
late
act
proinflammatori
cytokin
contribut
endotoxininduc
ali
sepsisassoci
lethal
significantli
inhibit
oroa
iv
administ
hr
hr
lp
challeng
vascular
endotheli
injuri
play
critic
role
onset
ali
character
disrupt
alveolarcapillari
interfac
promot
pmn
inflammatori
exud
enter
alveoli
lung
inflamm
proinflammatori
factor
may
impair
homeostasi
lung
microvascular
permeabl
prerequisit
pmn
sequestr
lung
present
studi
demonstr
oroa
posttreat
iv
suppress
sequestr
pmn
also
attenu
format
pulmonari
edema
oroa
appear
reliev
edema
protect
endotheli
function
allevi
neutrophil
sequestr
addit
lpsinduc
overproduct
caus
vascular
endotheli
cell
injuri
increas
vascular
permeabl
lung
effect
lp
prevent
intraven
oroa
result
provid
addit
evid
support
oroa
exhibit
potent
anticytokin
effect
benefici
prevent
vascular
endotheli
injuri
ali
potent
vasodil
gener
larginin
catalyz
ino
produc
activ
alveolar
macrophag
lp
stimul
overproduct
induc
lp
facilit
progress
lung
inflamm
anesthet
model
ali
use
present
studi
plasma
increas
lp
challeng
increas
significantli
revers
oroa
mgkg
iv
administ
hr
hr
lp
challeng
consist
previou
report
oroa
block
ino
gene
express
suppress
inoscatalyz
product
macrophag
support
result
present
inosimmunohistochemistri
ino
protein
assay
lp
induct
ino
neutrophil
clara
cell
lung
resid
alveolar
macrophag
prevent
oroa
mgkg
iv
posttreat
result
support
antiinflammatori
effect
oroa
present
result
wbc
number
oroatr
rat
return
almost
control
level
hour
lp
suggest
oroa
regul
circul
wbc
earli
transient
oroa
effect
howev
similar
transient
effect
lp
circul
wbc
furthermor
hr
lp
fig
increas
ino
product
still
markedli
suppress
oroa
circul
wbc
return
normal
level
oroa
appear
possess
multisit
action
earli
later
phase
endotoxemia
thu
oroa
exhibit
benefici
effect
manag
endotoxemia
earli
applic
effect
transient
strateg
logic
administ
oroa
earli
possibl
block
earli
event
inflamm
lp
challeng
may
decreas
subsequ
releas
cytokin
develop
irrevers
damag
due
releas
well
establish
lpsinduc
immunolog
cascad
respons
complic
although
tnf
respons
follow
lpstreatment
earli
transient
possibl
tnf
initi
cascad
event
return
basal
level
evidenc
increas
product
ino
late
act
cytokin
howev
difficult
claim
tnf
respons
mediat
pathogenesi
lung
injuri
anim
model
sinc
use
recombin
tnf
fusion
protein
approach
block
tnf
activ
regardless
present
studi
demonstr
oroa
possess
multisit
action
earli
later
phase
endotoxemia
key
transcript
factor
respons
host
defens
infect
unstimul
condit
present
cytosol
bound
inhibitori
protein
follow
lp
challeng
transloc
nucleu
drive
express
varieti
inflammatori
gene
involv
pathogenesi
ali
therefor
blockad
activ
expect
attenu
ali
support
result
present
studi
demonstr
oroa
posttreat
inhibit
activ
releas
consist
notion
oroa
prevent
lpsinduc
releas
via
activ
surviv
rate
experiment
anim
import
indic
evalu
possibl
therapeut
benefit
potenti
drug
found
mice
die
hr
receiv
lethal
dose
lp
result
similar
found
other
fatal
mice
howev
significantli
reduc
anim
given
oroa
mgkg
ip
hr
hr
lp
treatment
suggest
oroa
use
candid
manag
endotoxemia
septic
shock
studi
demonstr
anim
model
sepsi
lung
injuri
corticosteroid
baicalein
flavonoid
ethyl
pyruv
given
simultan
lpsinduc
experiment
insult
protect
anim
multipl
organ
dysfunct
decreas
mortal
rate
benefici
effect
posttreat
drug
ard
experiment
anim
patient
high
risk
howev
report
addit
drug
significantli
prevent
thicken
intraalveolar
septa
inhibit
monocyt
migrat
later
stage
lung
injuri
clinic
practic
high
dose
corticosteroid
mgkg
suppress
infiltr
inflammatori
leukocyt
product
cytokin
develop
fibrot
chang
lung
fact
patient
receiv
corticosteroid
increas
collagen
deposit
increas
lung
injuri
suggest
corticosteroid
clinic
effect
administ
later
phase
lung
injuri
summari
oroa
posttreat
significantli
attenu
lpsinduc
lung
injuri
significantli
increas
surviv
rate
endotoxem
anim
oroa
amelior
lpsinduc
ali
involv
inhibit
activ
blockad
releas
earli
lateact
cytokin
oroa
also
inhibit
express
cyclooxygenas
known
play
role
lung
inflamm
furthermor
preliminari
studi
demonstr
post
treatment
oroa
significantli
revers
system
hypotens
improv
cardiac
inotropi
lpstreat
rat
oroa
therefor
potenti
use
compound
provid
new
strategi
clinic
prevent
treatment
ard
sepsi
male
spraguedawley
rat
weigh
g
mice
weigh
g
maintain
standard
condit
tzu
chi
univers
anim
center
use
experiment
procedur
approv
anim
care
use
committe
tzu
chi
univers
rat
anesthet
intraperiton
ip
urethan
gkg
purchas
sigmaaldrich
chemic
st
loui
mo
left
right
femor
arteri
cannul
record
blood
pressureheart
rate
administ
experiment
drugscollect
blood
sampl
respect
anim
allow
stabil
min
lipopolysaccharid
serotyp
escherichia
coli
lp
sigmaaldrich
chemic
dissolv
steril
physiolog
salin
immedi
use
invas
procedur
oper
asept
condit
lp
administr
anim
monitor
chang
mean
arteri
pressur
map
heart
rate
hr
hr
anim
divid
randomli
group
ivsal
hivsolv
control
group
hr
iv
inject
normal
salin
sal
anim
administ
solvent
solv
sal
plu
tween
ratio
iv
ivlp
group
hr
receiv
lp
mgkg
iv
anim
administ
solv
iv
ivlp
group
hr
lp
iv
challeng
anim
administ
oroa
mgkg
iv
ivlp
group
hr
lp
iv
challeng
anim
administ
solv
iv
ivlp
group
hr
lp
iv
challeng
anim
administ
oroa
mgkg
iv
twenti
four
hour
lp
challeng
anim
group
sacrif
anesthesia
variou
tissu
remov
examin
supernat
blood
sampl
also
collect
frozen
subsequ
assay
immedi
draw
wbc
whole
blood
sampl
contain
uml
heparin
count
automat
multiparamet
blood
cell
counter
model
sysmex
hyogo
japan
plasma
concentr
measur
enzymelink
immunosorb
assay
rat
bender
medsystem
vienna
austria
accord
manufactur
instruct
plasma
measur
griess
reaction
frozen
plasma
sampl
thaw
deprotein
incub
ethanol
sigma
chemic
min
centrifug
min
rpm
one
hundr
supernat
sampl
incub
min
griess
reagent
contain
dihydrochlorid
sulfanilamid
phosphor
acid
sigma
chemic
plate
standard
nitrit
salt
sigma
chemic
solut
use
absorb
reaction
product
measur
nm
plasma
nitrit
concentr
calcul
standard
curv
lung
tissu
remov
dehydr
embed
paraffin
cut
section
process
ihc
section
incub
antigen
retriev
buffer
contain
mm
trisodium
citrat
tween
ph
min
wash
phosphatebuff
salin
pb
permeabl
triton
pb
min
nonspecif
stain
block
normal
serum
block
reagent
biogenx
san
ramon
ca
min
follow
incub
antiino
mous
antibodi
bd
bioscienc
nj
usa
overnight
super
enhanc
solut
biogenx
san
ramon
ca
ad
min
poli
horseradish
peroxidas
conjug
antimous
igg
reagent
appli
min
follow
avidinbiotinperoxidas
complex
substrat
dab
cell
nuclei
counterstain
hematoxylin
sec
section
obtain
tissu
block
per
anim
anim
section
per
anim
randomli
select
statist
analysi
section
mount
watersolubl
mount
medium
examin
light
microscop
leica
leica
microsystem
wetzlar
germani
singl
blind
fashion
standard
techniqu
use
briefli
paraffinembed
tissu
section
lung
process
antigen
retriev
buffer
permabil
triton
min
block
nonspecif
interact
normal
serum
biogenx
hr
follow
wash
reaction
mous
monoclon
antibodi
cell
signal
antimous
igg
hilyt
fluor
antibodi
anaspec
cell
nuclei
counterstain
dapi
kpl
washington
dc
usa
min
section
obtain
tissu
block
per
anim
anim
section
per
anim
randomli
select
statist
analysi
section
mount
watersolubl
mount
media
examin
fluoresc
microscop
leica
leica
microsystem
wetzlar
germani
frozen
lung
tissu
homogen
buffer
contain
pb
phosphatas
inhibitor
nuclear
extract
kit
activ
motif
carlsbad
ca
centrifug
rpm
min
result
pellet
resuspend
hypoton
buffer
incub
min
nuclei
isol
centrifug
rpm
min
supernat
contain
cytoplasm
membran
protein
collect
store
pellet
resuspend
complet
lyse
buffer
nuclear
extract
recov
centrifug
rpm
min
supernat
collect
store
immunoblot
protein
concentr
quantifi
bicinchonin
acid
bca
protein
assay
reagent
pierc
chemic
rockford
il
aliquot
extract
dilut
ratio
sampl
buffer
triscl
ph
sodium
dodecyl
sulfat
sd
bromophenol
blue
glycerol
boil
min
protein
extract
quantit
simultan
ensur
subsequ
equal
protein
load
protein
extract
separ
sd
polyacrylamid
gel
protein
per
lane
transfer
onto
polyvinyliden
difluorid
membran
biorad
hercul
ca
semidri
electroblot
amersham
bioscienc
buckinghamshir
uk
min
blot
block
hr
room
temperatur
nonfat
milk
trisbuff
salin
tween
wash
tbst
buffer
solut
membran
hybrid
mous
ino
monoclon
igg
bd
transduct
california
usa
mous
monoclon
igg
abcam
cambridg
uk
mous
monoclon
igg
santa
cruz
biotechnolog
california
usa
rabbit
monoclon
antibodi
santa
cruz
biotechnolog
immunoreact
enhanc
solut
toyobo
osaka
japan
overnight
wash
blot
expos
horseradish
peroxidaseconjug
antimous
igg
antirabbit
secondari
antibodi
kpl
washington
dc
usa
hr
room
temperatur
immunoreact
visual
use
enhanc
chemiluminesc
elc
detect
system
perkinelm
life
scienc
massachusett
usa
strip
blot
reporb
mous
antiactin
antibodi
chemicon
illinoi
usa
rabbit
histon
polyclon
cell
signal
technolog
beverli
ca
normal
equal
protein
load
scan
blot
comput
individu
band
analyz
imag
j
softwar
nation
institut
mental
health
right
lung
remov
wet
weight
obtain
lung
tissu
weigh
day
dri
wettodri
wd
ratio
calcul
follow
wd
ratio
wet
weightdri
weight
dri
weight
lung
specimen
fix
paraformaldehyd
ph
sigma
chemic
overnight
room
temperatur
wash
tap
water
min
specimen
dehydr
grade
seri
ethanol
min
min
hr
min
sigma
chemic
embed
paraffin
two
section
place
glass
slide
dri
overnight
slide
deparaffin
nonxylen
solut
time
min
per
time
rehydr
ethanol
twice
total
min
min
min
specimen
process
hematoxylin
min
stain
eosin
sec
section
incub
nonxylen
solut
sigma
chemic
min
mount
coverslip
specimen
examin
light
microscop
leica
microsystem
assess
done
singl
blind
fashion
section
obtain
tissu
block
per
anim
anim
section
per
anim
randomli
select
statist
analysi
lung
injuri
score
estim
base
histolog
examin
includ
hemorrhag
intraalveolar
septa
cell
infiltr
lung
wettodri
ratio
score
determin
injuri
sever
sever
sever
greater
sever
degre
intraalveolar
septa
hemorrhag
score
hemorrhag
mild
hemorrhag
sever
hemorrhag
thick
intraalveolar
septa
quantifi
measur
septa
along
crosshair
place
imag
septa
anim
use
imag
j
softwar
lung
wettodri
ratio
determin
pulmonari
edema
score
edema
mild
edema
sever
edema
compar
control
group
mice
use
evalu
surviv
rate
pilot
studi
demonstr
lp
mgkg
ip
caus
death
mice
mgkg
ip
lp
caus
approxim
lethal
furthermor
oroa
mgkg
mgkg
mgkg
ip
improv
surviv
consist
report
other
endotoxininduc
sever
sensit
lower
mice
rat
parker
et
al
reason
higher
dose
lp
oroa
use
studi
surviv
rate
mice
mice
given
lethal
dose
lp
mgkg
ip
induc
endotoxemia
divid
randomli
group
ipsal
control
group
hr
hr
receiv
normal
salin
sal
ip
mice
administ
solvent
solv
ip
sal
plu
tween
ratio
examin
differ
time
point
hr
iplp
group
hr
hr
receiv
lp
mgkg
ip
mice
administ
solv
ip
examin
hr
iplp
group
hr
lp
ip
challeng
oroa
mgkg
ip
administ
examin
hr
iplp
group
hr
lp
challeng
oroa
mgkg
ip
administ
examin
hr
iplp
group
hr
lp
ip
challeng
oroa
mgkg
ip
administ
examin
hr
ipsal
group
hr
normal
salin
sal
ip
challeng
oroa
mgkg
ip
administ
examin
hr
oroa
isol
purifi
accord
previou
report
dissolv
normal
salin
plu
tween
ratio
use
ultrason
experi
mgml
stock
solut
oroa
dilut
mgml
work
concentr
normal
salin
e
coli
lp
dilut
normal
salin
concentr
mgml
use
experiment
data
present
oneway
twoway
anova
use
determin
differ
measur
singl
time
point
compar
use
student
unpair
ttest
surviv
rate
analyz
kaplanmey
surviv
curv
chisquar
test
use
test
signific
p
valu
less
consid
statist
signific
